Search Our Site
Search Results
346 Results Found
AIDS confab hears bad news about funding, good news about PrEP
The 25th International AIDS Conference kicked off Monday, July 22, in Munich, Germany with calls to redouble efforts to end the global epidemic as funding cuts and threats to the rights of LGBTQ people and other vulnerable populations jeopardize progress.
German researcher says another man is cured of HIV after stem cell transplant
A seventh person, dubbed "the next Berlin Patient," appears to be cured of HIV after a stem cell transplant for cancer treatment, according to a report at a press briefing ahead of the International AIDS Conference.
Fauci talks about AIDS and COVID during SF visit
With his new memoir a national bestseller, Dr. Anthony Fauci was in San Francisco recently to talk about his accomplishments and regrets over half a century as a leading national health official.
Research shows twice-yearly PrEP injections prevent HIV in women
Lenacapavir, a twice-yearly injectable antiretroviral, demonstrated 100% effectiveness for preventing HIV acquisition in a large study of young cisgender women in Africa, Gilead Sciences announced June 20.
CDC finalizes doxyPEP guidelines for STI prevention
The federal Centers for Disease Control and Prevention has released guidelines for using the antibiotic doxycycline as post-exposure prophylaxis to prevent sexually transmitted infections – an approach known as doxyPEP.
SF DPH and CDC urge mpox vaccination
With Pride coming up, the San Francisco Department of Public Health and the federal Centers for Disease Control and Prevention are urging people at risk for mpox, to receive two doses of the Jynneos vaccine to protect themselves from the disease.
New HIV cases continue to decline, CDC finds
New HIV infections in the U.S. continue to fall, with the greatest declines seen among gay and bisexual men, young people, and people living in the South, according to a set of HIV surveillance reports from the Centers for Disease Control and Prevention.
STIs fall in SF after doxyPEP rollout
The early rollout of doxyPEP in San Francisco has contributed to a decline in sexually transmitted infections, according to studies presented March 4 at the Conference on Retroviruses and Opportunistic Infections in Denver.
CDC: Many factors contribute to high HIV risk for trans women
Several factors, including discrimination, homelessness, and violence, help explain why transgender women have a higher risk for HIV, according to a report from the federal Centers for Disease Control and Prevention.
Gay men account for a large share of STIs
Syphilis is surging in the United States, but cases of chlamydia have leveled off and gonorrhea has declined, according to the latest sexually transmitted infections surveillance report.
Last large HIV vaccine trial fails
The last large HIV vaccine study has been halted ahead of schedule after researchers determined "there is little or no chance of the trial demonstrating vaccine efficacy in preventing HIV acquisition," according to a December 6 announcement.
Deadly mpox outbreak reported in Democratic Republic of the Congo
The Democratic Republic of the Congo in Africa is in the midst of an mpox outbreak that has led to nearly 600 deaths, according to the World Health Organization.
Latinos now have highest rate of new SF HIV cases
The 2022 HIV epidemiology report released by the San Francisco Department of Public Health Tuesday showed that for the first time, Latino men had a higher HIV diagnosis rate than Black men.
Study suggests PEP-in-pocket is another HIV prevention option
Having antiretrovirals on hand to take as post-exposure prophylaxis after potential HIV exposure, an approach known as PEP-in-pocket, or PIP, is a feasible prevention option, according to study results presented at the recent IDWeek conference in Boston.
CDC issues first doxyPEP guidelines for STI prevention
The federal Centers for Disease Control and Prevention issued its first proposed guidelines for using the antibiotic doxycycline as post-exposure prophylaxis to prevent sexually transmitted infections, an approach known as doxyPEP.
CDC recommends updated COVID shots for all
The Centers for Disease Control and Prevention urges all Americans ages 6 months and older to get updated COVID vaccines that more closely match current coronavirus variants.
Expert panel recommends all types of PrEP
The U.S. Preventive Services Task Force released a recommendation this week calling on health care providers to prescribe all approved PrEP options for people at increased risk for HIV.
Lesbian Dr. Jeanne Marrazzo tapped to head NIAID
Dr. Jeanne Marrazzo, a world-acclaimed expert on HIV and sexually transmitted infections, has been chosen to head the National Institute of Allergy and Infectious Diseases, replacing Dr. Anthony Fauci.
HIV confab hears news about heart disease, mpox
The International AIDS Society Conference on HIV Science, held recently in Brisbane, Australia, included new findings on a medication to prevent heart disease and the risk of severe mpox among people living with HIV.
People with undetectable HIV have zero transmission risk, WHO says
In a move long encouraged by advocates, the World Health Organization has reaffirmed that people with HIV who consistently take antiretroviral treatment and maintain an undetectable viral load do not transmit the virus during sex, a concept known as U=U.